Login / Signup
One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
Michael Pazianas
Published in:
Calcified tissue international (2022)
Keyphrases
</>
end stage renal disease
chronic kidney disease
bone mineral density
newly diagnosed
ejection fraction
combination therapy